Metabolic Reprogramming in Renal Tubular Cells in Acute Kidney Injury Following Severe Trauma

NCT ID: NCT06167512

Last Updated: 2024-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-27

Study Completion Date

2025-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Severe trauma remains the leading cause of death in people under 50, and is associated with high morbidity, including severe disability, with a substantial socio-economic impact. Secondary to trauma, multiple mechanisms (inflammatory, ischemic, oxidative, etc.) setting in rapidly, leads to organ failure, one of the three first cause of death. Vascular damage, with vasoplegia, renal damage, with acute kidney injury (AKI), and pulmonary damage, with acute respiratory distress syndrome (ARDS), are the most frequently observed but all organs can be affected whatever the type of trauma. For these reasons, identifying the pathophysiological pathways involved in organ failure induced by severe trauma is a major step towards limiting the morbidity and mortality induced by trauma, and proposing therapies to prevent them.

Because of the variability of lesions in these patients, and the multiplicity of pathways activated, the mechanisms involved and their causality with organ failure following severe trauma, are still poorly understood. Given their frequency and importance in terms of morbidity and mortality, the investigators decided to take a particular interest in the mechanisms leading to renal and pulmonary injury. The investigators' hypothesis is that the study of urinary and blood markers not performed as part of clinical routine would provide a better understanding of the pathophysiological mechanisms leading to organ failure secondary to severe trauma, and more specifically to renal and pulmonary injuries. With TRAUMATEC study, the investigators will explore mechanisms leading to AKI and ARDS through blood and urine samples of 60 severe trauma patients sampled over the first 48 hours after ICU admission and a reference of 20 healthy volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators plan to include 60 patients over 18 years old with severe trauma, defined with an ISS≥9 and 20 healthy volunteers 18 years old as a reference group.

Blood and urine samples will be collected at ICU arrival, 12-, 24- and 48- hours after ICU admission. Specific dosages will then be realized on blood and urines to study metabolic and hormonal pathway leading to AKI and ARDS.

The primary objective of the study is to explore the association between renal metabolic changes and renal function impairment following severe trauma.

Secondary objectives are (1) to explore mitochondrial changes observed at the renal cellular level, on in vitro renal culture cells after exposure to trauma patient serum (2) to explore the association between plasma metabolic changes and renal and pulmonary function impairment following severe trauma (3) to explore the association between hormonal metabolic changes and renal and pulmonary function impairment following severe trauma (4) to explore the association between red blood cell-induced oxidative stress and renal function impairment following severe trauma (5) to explore the association between changes in the hemoglobin recycling (chelation) system and impaired renal function following severe trauma (6) to explore renal tubular damage secondary to severe trauma (7) to explore the pathophysiological mechanisms associated with pulmonary damage following severe trauma (8) to describe mortality at day 30.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multi-organ Failure After Severe Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

polytrauma patients

polytrauma patients

No interventions assigned to this group

healthy volunteers

healthy volunteers

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Trauma patients :

* Adult patients (age ≥ 18 years)
* Patient admitted for suspected severe trauma (1 Vittel criteria)
* Injury Severity Score ≥ 9
* Health insurance
* Written consent obtained from the patient or trusted support person / family member / close friend, or inclusion in an emergency situation and written consent obtained from the patient (trusted support person / family member / close friend if necessary) as soon as possible (article L1122-1-2 of the CSP).

Healthy volunteers :

* Adult patients (≥ 18 years)
* Affiliated with health insurance
* Written informed consent́
* Patient respecting matching

Exclusion Criteria

Trauma patients :

* Pregnant patient
* Minor patient
* Adult under guardianship, curatorship or safeguard of justice
* Patient under Aide Médicale d'État
* Chronic renal failure on dialysis
* Chronic respiratory disease
* Patient with chronic cardiac insufficiency
* Systemic inflammatory disease

Healthy volunteers :

* Pregnant patient
* Minor patient
* Adult under guardianship, curatorship or safeguard of justice
* Patient under Aide Médicale d'État
* Patient with chronic renal failure on dialysis
* Chronic respiratory disease
* Patient with chronic cardiac insufficiency
* Systemic inflammatory disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bicetre hospital

Le Kremlin-Bicêtre, , France

Site Status RECRUITING

Bicetre hospital

Le Kremlin-Bicêtre, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marie Werner

Role: primary

01 45 21 34 41

Laurent Becquemont

Role: primary

01 47 10 77 87

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01597-38

Identifier Type: OTHER

Identifier Source: secondary_id

APHP231084

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A NEW WAY TO DETECT ACUTE KIDNEY INJURY
NCT07198906 NOT_YET_RECRUITING
Immune Function in Acute Kidney Injury
NCT02470507 ACTIVE_NOT_RECRUITING
Outcome of ECMO and CRRT.
NCT05033509 COMPLETED